Nuclear Radiology: Page 69

Eckert & Ziegler posts higher 6-month results
By AuntMinnieEurope.com staff writers
Growth among all of its product segments powered Eckert & Ziegler Group to increased revenues and profits in the first six months of 2011.
August 2, 2011
Growth predicted for global imaging market
By AuntMinnieEurope.com staff writers
The market for diagnostic imaging modalities is expected to grow from $20.7 billion in 2010 to $26.6 billion by 2016, according to a new report published this month by market research company MarketsandMarkets.
July 27, 2011
Stem cell regeneration of heart tissue methods await refining
By Eric Barnes
An original paper in European Radiology scans the many promising developments in stem cell regeneration of cardiac tissue following myocardial infarction. Researchers from the Netherlands find there is no "best method" in cell tracking but rather an array of techniques.
July 26, 2011
FDG-PET/CT helps detect sarcoidosis in extremities
By Wayne Forrest
Researchers from Maastricht University Medical Centre in the Netherlands discovered a substantial number of sarcoidosis cases in the extremities using FDG-PET/CT, whereas a majority of those same lesions could not be detected by low-dose CT.
July 24, 2011
Neoprobe eyes European market
By AuntMinnieEurope.com staff writers
Gamma camera probe developer Neoprobe has established a European business unit to address European Union development and commercialization needs for its technologies, including its Lymphoseek radiopharmaceutical.
July 19, 2011
GE launches MIND Coalition
By AuntMinnieEurope.com staff writers
GE Healthcare has unveiled its new Making an Impact on Neurodegenerative Diseases (MIND) initiative to help physicians improve the worldwide detection, diagnosis, and management of neurological conditions such as Alzheimer's and Parkinson's disease.
July 14, 2011
France invests in nuclear medicine
By AuntMinnieEurope.com staff writers
French President Nicolas Sarkozy has confirmed plans to invest 1 billion euros in future nuclear programs, including a fourth-generation reactor research, according to a report in World Nuclear News.
June 29, 2011
Lantheus launches phase III flurpiridaz F-18 trial
By AuntMinnieEurope.com staff writers
Lantheus Medical Imaging has launched the first of two phase III clinical trials of a PET radiopharmaceutical for use in detecting coronary artery disease.
June 29, 2011
Aspect Imaging partners with Cage
By AuntMinnieEurope.com staff writers
Aspect Imaging has signed an agreement with Cage Chemicals to develop and manufacture Aspect's PhenoQuant line of contrast agents for preclinical research.
June 28, 2011
Germany allocates funds for Mo-99 production
By AuntMinnieEurope.com staff writers
The German Federal Ministry of Health has awarded more than 1 million euros ($1.4 million U.S.) in R&D funding for producing the radioisotope molybdenum-99 (Mo-99) at the research neutron source Forschungs-Neutronenquelle Heinz Maier-Leibnitz (FRM II).
June 27, 2011
Philips inks nuclear medicine deal with Russia
By AuntMinnieEurope.com staff writers
Philips Healthcare parent Royal Philips Electronics and Rosatom, the Russian State Atomic Energy Corporation, have signed a nuclear medicine research and manufacturing deal.
June 19, 2011
IBA, Wilex meet FDA on Redectane trial
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) and drug company Wilex recently met with the U.S. Food and Drug Administration to discuss the regulatory review process for IBA's Redectane PET/CT radiopharmaceutical.
June 19, 2011
Previous Page
Page 69 of 90
Next Page